336 

14 CFR Ch. I (1–1–19 Edition) 

§ 125.221 

including a description of the deviation 
and the reasons for it. 

(f) 

Portable oxygen concentrators

—(1) 

Acceptance criteria. 

A passenger may 

carry or operate a portable oxygen con-
centrator for personal use on board an 
aircraft and a certificate holder may 
allow a passenger to carry or operate a 
portable oxygen concentrator on board 
an aircraft operated under this part 
during all phases of flight if the port-
able oxygen concentrator satisfies all 
of the requirements in this paragraph 
(f): 

(i) Is legally marketed in the United 

States in accordance with Food and 
Drug Administration requirements in 
title 21 of the CFR; 

(ii) Does not radiate radio frequency 

emissions that interfere with aircraft 
systems; 

(iii) Generates a maximum oxygen 

pressure of less than 200 kPa gauge 
(29.0 psig/43.8 psia) at 20 

°

C (68 

°

F); 

(iv) Does not contain any hazardous 

materials subject to the Hazardous Ma-
terials Regulations (49 CFR parts 171 
through 180) except as provided in 49 
CFR 175.10 for batteries used to power 
portable electronic devices and that do 
not require aircraft operator approval; 
and 

(v) Bears a label on the exterior of 

the device applied in a manner that en-
sures the label will remain affixed for 
the life of the device and containing 
the following certification statement 
in red lettering: ‘‘The manufacturer of 
this POC has determined this device 
conforms to all applicable FAA accept-
ance criteria for POC carriage and use 
on board aircraft.’’ The label require-
ments in this paragraph (f)(1)(v) do not 
apply to the following portable oxygen 
concentrators approved by the FAA for 
use on board aircraft prior to May 24, 
2016: 

(A) AirSep Focus; 
(B) AirSep FreeStyle; 
(C) AirSep FreeStyle 5; 
(D) AirSep LifeStyle; 
(E) Delphi RS–00400; 
(F) DeVilbiss Healthcare iGo; 
(G) Inogen One; 
(H) Inogen One G2; 
(I) Inogen One G3; 
(J) Inova Labs LifeChoice; 

(K) Inova Labs LifeChoice Activox; 
(L) International Biophysics 

LifeChoice; 

(M) Invacare Solo2; 
(N) Invacare XPO2; 
(O) Oxlife Independence Oxygen Con-

centrator; 

(P) Oxus RS–00400; 
(Q) Precision Medical EasyPulse; 
(R) Respironics EverGo; 
(S) Respironics SimplyGo; 
(T) SeQual Eclipse; 
(U) SeQual eQuinox Oxygen System 

(model 4000); 

(V) SeQual Oxywell Oxygen System 

(model 4000); 

(W) SeQual SAROS; and 
(X) VBox Trooper Oxygen Concen-

trator. 

(2) 

Operating requirements. 

Portable 

oxygen concentrators that satisfy the 
acceptance criteria identified in para-
graph (f)(1) of this section may be car-
ried or used by a passenger on an air-
craft provided the aircraft operator en-
sures that all of the conditions in this 
paragraph (f)(2) are satisfied: 

(i) 

Exit seats. 

No person operating a 

portable oxygen concentrator is per-
mitted to occupy an exit seat. 

(ii) 

Stowage of device. 

During move-

ment on the surface, takeoff and land-
ing, the device must be stowed under 
the seat in front of the user, or in an-
other approved stowage location so 
that it does not block the aisle way or 
the entryway to the row. If the device 
is to be operated by the user, it must 
be operated only at a seat location that 
does not restrict any passenger’s access 
to, or use of, any required emergency 
or regular exit, or the aisle(s) in the 
passenger compartment. 

[Docket No. 19779, 45 FR 67235, Oct. 9, 1980, as 
amended by Docket FAA–2014–0554, Amdt. 
125–65, 81 FR 33119, May 24, 2016; Docket 
FAA–2018–0119, Amdt. 125–68, 83 FR 9173, Mar. 
5, 2018] 

§ 125.221

Icing conditions: Operating 

limitations. 

(a) No pilot may take off an airplane 

that has frost, ice, or snow adhering to 
any propeller, windshield, stabilizing 
or control surface; to a powerplant in-
stallation; or to an airspeed, altimeter, 

VerDate Sep<11>2014 

08:20 May 17, 2019

Jkt 247048

PO 00000

Frm 00346

Fmt 8010

Sfmt 8002

Y:\SGML\247048.XXX

247048